Clinical Trial Update: Study on Androgen Receptor and Triple Negative Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating androgen receptor targeted therapy in triple-negative breast cancer with androgen receptor positivity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: UNICANCER | Conditions: Breast Cancer Female, Triple Negative and Androgen Receptor Positive | Phase 2 | Status: COMPLETED